AKTS · Forms 3, 4, 5
Insider trades at Aktis Oncology, Inc.
1 insider sold $259K of Aktis Oncology, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Aktis Oncology, Inc. (AKTS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Akos Czibere | Chief Medical Officer | Option exercise | 12,500 | $4.95 | $62K | Form 4 | |
| Akos Czibere | Chief Medical Officer | Sell | 5,099 | $20.19 | $103K | Form 4 | |
| Akos Czibere | Chief Medical Officer | Sell | 7,401 | $21.03 | $156K | Form 4 | |
| Ken Herrmann | Director | Option exercise | 3,506 | $0.08 | $280 | Form 4 | |
| Ken Herrmann | Director | Option exercise | 1,350 | $1.91 | $3K | Form 4 | |
| Ken Herrmann | Director | Sell | 3,506 | $24.56 | $86K | Form 4 | |
| Ken Herrmann | Director | Sell | 1,350 | $24.56 | $33K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.